Overview
This one hour webinar will feature two presentations and a question/answer session.
Making a Diagnosis - David Palma, MD, PhD
This presentation will review the normal imaging findings after stereotactic radiation for lung cancer and will review strategies to diagnose recurrence and distinguish it from fibrosis.
Salvage Therapies and Outcomes - Eric Brooks, MD, MHS
Dr. Brooks will speak on how to select salvage therapy for patients who experience isolated local/regional recurrences of their early-stage NSCLC after SABR (up to 1 in 6 patients), and associated outcomes. This talk is aimed toward a large, multidisciplinary audience, including thoracic surgeons, oncologists, radiation oncologists, and interventional radiologists. The goal is to help inform clinicians of the management of these potentially curable but complex patients in routine clinical practice.
Following the presentations, Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.
After attending this program learners will be able to:
- Provide an update on the optimal management of patients with recurrent early-stage NSCLC following stereotactic radiation for lung cancer.
- Review strategies to diagnose recurrence and distinguish it from fibrosis.
- Address how to select salvage therapy for patients who experience recurrence after SABR.
- Assess proposed or ongoing clinical trials that are likely to impact patient care in the near future.
Moderator: Professor S. Senan
MRCP, FRCR, PhD,Department of Radiation Oncology, Cancer Center Amsterdam, VU University Medical Center.
Dr. David Palma
MD, PhD, Radiation Oncologist, London Health Sciences Centre, Clinician-Scientist, Ontario, Institute for Cancer Research.
Eric Brooks
MD, MHS, Resident Physician,MD Anderson Cancer Center, Houston, TX, USA.
For any inquiries, please contact meetings@iaslc.org.
Making a Diagnosis - David Palma, MD, PhD
This presentation will review the normal imaging findings after stereotactic radiation for lung cancer and will review strategies to diagnose recurrence and distinguish it from fibrosis.
Salvage Therapies and Outcomes - Eric Brooks, MD, MHS
Dr. Brooks will speak on how to select salvage therapy for patients who experience isolated local/regional recurrences of their early-stage NSCLC after SABR (up to 1 in 6 patients), and associated outcomes. This talk is aimed toward a large, multidisciplinary audience, including thoracic surgeons, oncologists, radiation oncologists, and interventional radiologists. The goal is to help inform clinicians of the management of these potentially curable but complex patients in routine clinical practice.
Following the presentations, Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.
After attending this program learners will be able to:
- Provide an update on the optimal management of patients with recurrent early-stage NSCLC following stereotactic radiation for lung cancer.
- Review strategies to diagnose recurrence and distinguish it from fibrosis.
- Address how to select salvage therapy for patients who experience recurrence after SABR.
- Assess proposed or ongoing clinical trials that are likely to impact patient care in the near future.
Moderator: Professor S. Senan
MRCP, FRCR, PhD,Department of Radiation Oncology, Cancer Center Amsterdam, VU University Medical Center.
Dr. David Palma
MD, PhD, Radiation Oncologist, London Health Sciences Centre, Clinician-Scientist, Ontario, Institute for Cancer Research.
Eric Brooks
MD, MHS, Resident Physician,MD Anderson Cancer Center, Houston, TX, USA.
For any inquiries, please contact meetings@iaslc.org.